Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: Study Protocol.

被引：0
|
作者：
Calais, Jeremie [1 ]
Zhu, Shaojun [1 ]
Hrimas, Nader [2 ]
Eiber, Matthias [3 ]
Hadaschik, Boris [2 ]
Stuschke, Martin [2 ]
Herrmann, Ken [2 ]
Czernin, Johannes [1 ]
Kishan, Amar U. [1 ]
Nickols, Nicholas G. [1 ]
Elashoff, David [1 ]
Fendler, Wolfgang [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Essen Gesamthsch, Essen, Germany
[3] TUM, Munich, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT257
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
    Jeremie Calais
    Shaojun Zhu
    Nader Hirmas
    Matthias Eiber
    Boris Hadaschik
    Martin Stuschke
    Ken Herrmann
    Johannes Czernin
    Amar U. Kishan
    Nicholas G. Nickols
    David Elashoff
    Wolfgang P. Fendler
    BMC Cancer, 21
  • [2] Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol
    Calais, Jeremie
    Zhu, Shaojun
    Hirmas, Nader
    Eiber, Matthias
    Hadaschik, Boris
    Stuschke, Martin
    Herrmann, Ken
    Czernin, Johannes
    Kishan, Amar U.
    Nickols, Nicholas G.
    Elashoff, David
    Fendler, Wolfgang P.
    BMC CANCER, 2021, 21 (01)
  • [3] Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: Study protocol NCT04457245.
    Calais, Jeremie
    Zhu, Shaojun
    Hirmas, Nader
    Eiber, Matthias
    Hadaschik, Boris A.
    Stuschke, Martin
    Herrmann, Ken
    Czernin, Johannes
    Kishan, Amar Upadhyaya
    Nickols, Nicholas George
    Elashoff, David
    Fendler, Wolfgang Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [4] Update from the PSMA-dRT trial: A randomized phase III trial of PSMA-PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer
    Nikitas, John
    Lam, Ethan
    Booker, Kiara
    Fendler, Wolfgang
    Eiber, Matthias
    Hadaschik, Boris
    Herrmann, Ken
    Hirmas, Nader
    Lanzafame, Helena
    Stuschke, Martin
    Czernin, Johannes
    Steinberg, Michael
    Nickols, Nicholas
    Kishan, Amar
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [5] Update from the PSMA-dRT trial: A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer.
    Nikitas, John
    Lam, Ethan C.
    Booker, Kiara M.
    Fendler, Wolfgang P.
    Eiber, Matthias
    Hadaschik, Boris A.
    Herrmann, Ken
    Hirmas, Nader
    Lanzafame, Helena
    Stuschke, Martin
    Czernin, Johannes
    Steinberg, Michael L.
    Nickols, Nicholas George
    Kishan, Amar Upadhyaya
    Calais, Jeremie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 291 - 291
  • [6] Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)
    Nikitas, John
    Lam, Ethan
    Booker, Kiara Adame
    Fendler, Wolfgang P.
    Eiber, Matthias
    Hadaschik, Boris
    Herrmann, Ken
    Hirmas, Nader
    Lanzafame, Helena
    Stuschke, Martin
    Czernin, Johannes
    Steinberg, Michael L.
    Nickols, Nicholas G.
    Kishan, Amar U.
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (07) : 1076 - 1079
  • [7] The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer
    Hagens, Marinus J.
    Luining, Wietske I.
    Jager, Auke
    Donswijk, Maarten L.
    Cheung, Zing
    Wondergem, Maurits
    Oprea-Lager, Daniela E.
    Vis, Andre N.
    van Leeuwen, Pim J.
    van der Poel, Henk G.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (08) : 1238 - 1243
  • [8] PSMA PET/CT imaging for primary staging of intermediate and high-risk prostate cancer
    Cook, Gary J. R.
    Kulkarni, Meghana
    Warbey, Victoria S.
    BJU INTERNATIONAL, 2019, 124 (03) : 357 - 358
  • [9] PSMA PET/CT in the low- to intermediate-risk prostate cancer: when and why?
    Sofia, Luca
    Bauckneht, Matteo
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 584 - 586
  • [10] Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review
    Guglielmo, Priscilla
    Buffi, Nicolo
    Porreca, Angelo
    Setti, Lucia
    Arico, Demetrio
    Muraglia, Lorenzo
    Evangelista, Laura
    ANNALS OF NUCLEAR MEDICINE, 2025, 39 (03) : 247 - 254
12345